HK1199100A1 - Methods and compositions for the treatment and diagnosis of colorectal cancer - Google Patents
Methods and compositions for the treatment and diagnosis of colorectal cancerInfo
- Publication number
- HK1199100A1 HK1199100A1 HK14112559.2A HK14112559A HK1199100A1 HK 1199100 A1 HK1199100 A1 HK 1199100A1 HK 14112559 A HK14112559 A HK 14112559A HK 1199100 A1 HK1199100 A1 HK 1199100A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- diagnosis
- compositions
- treatment
- methods
- colorectal cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161529525P | 2011-08-31 | 2011-08-31 | |
| PCT/US2012/053518 WO2013033629A2 (fr) | 2011-08-31 | 2012-08-31 | Méthodes et compositions pour le traitement et le diagnostic du cancer colorectal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1199100A1 true HK1199100A1 (en) | 2015-06-19 |
Family
ID=47757193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14112559.2A HK1199100A1 (en) | 2011-08-31 | 2014-12-15 | Methods and compositions for the treatment and diagnosis of colorectal cancer |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20140221244A1 (fr) |
| EP (1) | EP2751561A4 (fr) |
| JP (1) | JP2014525586A (fr) |
| KR (1) | KR20140057354A (fr) |
| CN (1) | CN103907022A (fr) |
| AU (1) | AU2012301589A1 (fr) |
| CA (1) | CA2844822A1 (fr) |
| HK (1) | HK1199100A1 (fr) |
| WO (1) | WO2013033629A2 (fr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103901205B (zh) * | 2013-05-07 | 2016-06-15 | 普世华康江苏医疗技术有限公司 | Cystatin SN与CYFRA21-1在制备诊断和预示食管癌标志物中的应用 |
| CN103529220B (zh) * | 2013-10-12 | 2015-09-23 | 上海交通大学 | CTx在制备诊断结直肠癌药物中的用途 |
| KR20150105505A (ko) * | 2014-03-06 | 2015-09-17 | (주)노바셀테크놀로지 | 신규 대장암의 바이오마커 및 그를 표적으로 하는 항암제 |
| GB201505305D0 (en) | 2015-03-27 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel Peptides and combination of peptides for use in immunotherapy against various tumors |
| PT3388075T (pt) | 2015-03-27 | 2023-08-18 | Immatics Biotechnologies Gmbh | Novos péptidos e combinações de péptidos para uso em imunoterapia contra vários tumores |
| WO2017018735A1 (fr) * | 2015-07-24 | 2017-02-02 | 고려대학교 산학협력단 | Biomarqueur de détermination du vieillissement, de détermination de l'obésité, et de diagnostic du cancer et trousse de diagnostic l'utilisant |
| CN106928352B (zh) * | 2015-12-29 | 2020-01-14 | 中国医学科学院肿瘤医院 | 一种抗psg3蛋白的单克隆抗体及其杂交瘤细胞株与应用 |
| WO2017113565A1 (fr) * | 2015-12-29 | 2017-07-06 | 中国医学科学院肿瘤医院 | Kit pour le diagnostic auxiliaire d'un patient atteint d'un cancer du foie ou d'un cancer du tractus digestif basé sur un marqueur protéinique psg3 |
| CN105567846A (zh) * | 2016-02-14 | 2016-05-11 | 上海交通大学医学院附属仁济医院 | 检测粪便中细菌dna的试剂盒及其在大肠癌诊断中的应用 |
| SE540173C2 (en) * | 2016-04-20 | 2018-04-24 | Hiloprobe Ab | Marker genes for colorectal cancer classification, method for judging lymph node metastasis for prognosis of colorectal cancer and kit therefor |
| US11479820B2 (en) | 2016-10-27 | 2022-10-25 | Geneoscopy, Inc. | Detection method using eukaryotic cells |
| US11978535B2 (en) * | 2017-02-01 | 2024-05-07 | The Translational Genomics Research Institute | Methods of detecting somatic and germline variants in impure tumors |
| EP3802883A1 (fr) * | 2018-05-29 | 2021-04-14 | Turun yliopisto | L1td1 en tant que biomarqueur prédictif du cancer du côlon |
| CA3136405A1 (fr) * | 2018-06-01 | 2019-12-05 | Geneoscopy, Inc. | Methode de detection |
| CN108893534A (zh) * | 2018-06-26 | 2018-11-27 | 华中科技大学鄂州工业技术研究院 | 泛癌症诊断标记物 |
| WO2020085458A1 (fr) * | 2018-10-24 | 2020-04-30 | 味の素株式会社 | Procédé de test de muqueuse olfactive ou de fluide olfactif de mammifère |
| CN109402246B (zh) * | 2018-11-01 | 2021-07-06 | 固安博健生物技术有限公司 | L1td1基因及其表达产物的新用途 |
| WO2020205299A1 (fr) * | 2019-03-29 | 2020-10-08 | Case Western Reserve University | Détection de protéines biomarqueurs du cancer dans le sang |
| JP2020191834A (ja) * | 2019-05-29 | 2020-12-03 | 学校法人慶應義塾 | 消化器癌患者への癌免疫療法の適用の有効性を判定する方法 |
| KR102398735B1 (ko) * | 2019-07-02 | 2022-05-18 | 연세대학교 산학협력단 | 면역분석을 이용한 대장암의 분자적 분류방법 |
| MX2022007158A (es) * | 2019-12-13 | 2022-07-11 | Genentech Inc | Anticuerpos anti-ly6g6d y metodos de uso. |
| CN112501302A (zh) * | 2020-12-11 | 2021-03-16 | 山东大学第二医院 | 一种结直肠癌血清学诊断标志物及其应用 |
| WO2022182661A1 (fr) * | 2021-02-23 | 2022-09-01 | Board Of Regents, The University Of Texas System | Procédés pour le pronostic, le diagnostic et le traitement du cancer colorectal |
| CN113466458A (zh) * | 2021-06-29 | 2021-10-01 | 复旦大学附属中山医院 | Gpx4、nox1和acsl4在结直肠癌预后评价上的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09124698A (ja) * | 1995-10-27 | 1997-05-13 | Sagami Chem Res Center | ヒトｐｅｃ−６０様蛋白質およびそれをコードするｄｎａ |
| US5851987A (en) * | 1997-04-14 | 1998-12-22 | Incyte Pharmaceuticals, Inc. | Human tumor-associated Kazal inhibitor-like polypeptides and encoding polynucleotides |
| US6682890B2 (en) * | 2000-08-17 | 2004-01-27 | Protein Design Labs, Inc. | Methods of diagnosing and determining prognosis of colorectal cancer |
| US20060188889A1 (en) * | 2003-11-04 | 2006-08-24 | Christopher Burgess | Use of differentially expressed nucleic acid sequences as biomarkers for cancer |
| US20040157278A1 (en) * | 2002-12-13 | 2004-08-12 | Bayer Corporation | Detection methods using TIMP 1 |
| WO2007018316A1 (fr) * | 2005-08-09 | 2007-02-15 | Takeda Pharmaceutical Company Limited | Agent prophylactique/thérapeutique pour le cancer |
| US20100196889A1 (en) * | 2006-11-13 | 2010-08-05 | Bankaitis-Davis Danute M | Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer |
| EP1986010A1 (fr) * | 2007-04-05 | 2008-10-29 | Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg | Procédés et outils pour la discrimination d'adénomes et adénocarcinomes colorectaux |
| EP3056576B1 (fr) * | 2007-10-23 | 2019-02-13 | Clinical Genomics Pty Ltd | Procédé permettant de diagnostiquer des néoplasmes |
| KR101007567B1 (ko) * | 2007-10-30 | 2011-01-14 | 한국생명공학연구원 | 대장암 과발현 유전자를 이용한 대장암 진단 마커 |
| CN101386889A (zh) * | 2008-10-31 | 2009-03-18 | 芮屈生物技术（上海）有限公司 | 一种amacr基因的原位杂交检测试剂盒及其检测方法和应用 |
| CN101498700A (zh) * | 2009-02-16 | 2009-08-05 | 桑建利 | 人血液样本中脂类分子含量测定及其结直肠癌诊断试剂盒制备与应用 |
| WO2010125566A2 (fr) * | 2009-04-27 | 2010-11-04 | Technion Research And Development Foundation Ltd. | Marqueurs pour la détection d'un cancer |
| CN103097548A (zh) * | 2010-04-13 | 2013-05-08 | 纽约市哥伦比亚大学托管会 | 基于多癌症侵袭相关机制的生物标记 |
| AU2012272662A1 (en) * | 2011-06-22 | 2014-01-16 | Oncocyte Corporation | Methods and compositions for the treatment and diagnosis of cancer |
-
2012
- 2012-08-31 KR KR1020147007743A patent/KR20140057354A/ko not_active Application Discontinuation
- 2012-08-31 JP JP2014528668A patent/JP2014525586A/ja active Pending
- 2012-08-31 WO PCT/US2012/053518 patent/WO2013033629A2/fr active Application Filing
- 2012-08-31 AU AU2012301589A patent/AU2012301589A1/en not_active Abandoned
- 2012-08-31 EP EP12828342.1A patent/EP2751561A4/fr not_active Withdrawn
- 2012-08-31 CN CN201280051848.6A patent/CN103907022A/zh active Pending
- 2012-08-31 US US14/240,512 patent/US20140221244A1/en not_active Abandoned
- 2012-08-31 CA CA2844822A patent/CA2844822A1/fr not_active Abandoned
-
2014
- 2014-12-15 HK HK14112559.2A patent/HK1199100A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012301589A1 (en) | 2014-02-27 |
| CN103907022A (zh) | 2014-07-02 |
| JP2014525586A (ja) | 2014-09-29 |
| EP2751561A2 (fr) | 2014-07-09 |
| WO2013033629A2 (fr) | 2013-03-07 |
| US20140221244A1 (en) | 2014-08-07 |
| WO2013033629A3 (fr) | 2013-04-25 |
| CA2844822A1 (fr) | 2013-03-07 |
| EP2751561A4 (fr) | 2015-08-12 |
| KR20140057354A (ko) | 2014-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1199100A1 (en) | Methods and compositions for the treatment and diagnosis of colorectal cancer | |
| HK1199099A1 (en) | Methods and compositions for the treatment and diagnosis of cancer | |
| EP2723924A4 (fr) | Procédés et compositions permettant le traitement et le diagnostic du cancer | |
| EP2688594A4 (fr) | Procédés et compositions pour le traitement du cancer | |
| HK1202313A1 (en) | Methods and compositions for the treatment and diagnosis of bladder cancer | |
| EP2714081A4 (fr) | Méthodes, compositions et trousses pour le traitement du cancer | |
| EP2890815A4 (fr) | Méthodes de diagnostic et de traitement du cancer | |
| HK1178074A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| HK1200739A1 (en) | Diagnostic methods and compositions for treatment of cancer | |
| IL225471A0 (en) | Preparations and methods for the prevention and treatment of cancer | |
| EP2675469A4 (fr) | Compositions, dispositifs et procédés d'utilisation de celles-ci dans le traitement des cancers | |
| IL238177A0 (en) | Methods and preparations for the treatment of cancer | |
| GB201115711D0 (en) | Phyto-cannabinoids for use in the treatment of cancer | |
| HK1199290A1 (en) | Methods and compositions for the treatment and diagnosis of breast cancer | |
| HK1197276A1 (en) | Methods and compositions for the treatment and diagnosis of bladder cancer | |
| IL251083A0 (en) | Compounds and preparations for the treatment of cancer | |
| HK1201045A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| EP2558085A4 (fr) | Compositions et procédés pour la prévention et le traitement du cancer | |
| EP2700652A4 (fr) | Diagnostic et traitement du cancer à l'aide d'un anticorps anti-itm2a | |
| PT2605764E (pt) | Composições para o tratamento de cancro | |
| EP2635273A4 (fr) | Compositions d'isoflavonoïdes et méthodes de traitement du cancer | |
| GB201402983D0 (en) | Compositions and methods for treatment of metastatic cancer | |
| EP2687231A4 (fr) | Composition pour le traitement et le diagnostic du cancer du pancréas | |
| EP2928456A4 (fr) | Procédés et compositions pour le traitement du cancer | |
| EP2547368A4 (fr) | Méthodes et compositions pour le traitement du cancer |